Portfolio

Tropic Bio

CEO Gilad M. Gershon

Tropic is a pioneering tropical seeds company dedicated to the development of healthier, more robust, high-performing varieties of tropical crops. The company’s current core crop portfolio focuses on banana and rice, which together provide a source of livelihood to billions of people worldwide. Tropic utilises its proprietary GEiGS® platform and other cutting-edge gene editing technologies to develop improved crops with increased disease resistance, higher yields, and environmentally sustainable traits. By harnessing the power of advanced genetic engineering, Tropic is committed to addressing global agricultural challenges and providing innovative solutions that benefit farmers, consumers, and the environment.

Planetary Health

Tropic

Tropic BioSciences Ltd

Norwich Research Park
Innovation Centre
United Kingdom
NR4 7GJ

Year Invested

2026

Status

Current

Location

UK

Non Browning Bananas
“This funding is a powerful endorsement of our team’s ability to bring breakthrough products to the hands of growers, exporters and consumers around the world. We are entering a new era, one where gene‑edited crops will significantly enhance food security and sustainability."

Gilad M. Gershon

CEO

Gilad CEO Tropic

$105 Million

Series C financing to Scale Commercial Rollout of Gene-Edited Tropical Crops